These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides. Fong LG; Vickers TA; Farber EA; Choi C; Yun UJ; Hu Y; Yang SH; Coffinier C; Lee R; Yin L; Davies BS; Andres DA; Spielmann HP; Bennett CF; Young SG Hum Mol Genet; 2009 Jul; 18(13):2462-71. PubMed ID: 19376814 [TBL] [Abstract][Full Text] [Related]
7. MG132 Induces Progerin Clearance and Improves Disease Phenotypes in HGPS-like Patients' Cells. Harhouri K; Cau P; Casey F; Guedenon KM; Doubaj Y; Van Maldergem L; Mejia-Baltodano G; Bartoli C; De Sandre-Giovannoli A; Lévy N Cells; 2022 Feb; 11(4):. PubMed ID: 35203262 [TBL] [Abstract][Full Text] [Related]
8. [The role of lamins and mutations of LMNA gene in physiological and premature aging]. Sliwińska MA Postepy Biochem; 2007; 53(1):46-52. PubMed ID: 17718387 [TBL] [Abstract][Full Text] [Related]
9. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset. Kane MS; Lindsay ME; Judge DP; Barrowman J; Ap Rhys C; Simonson L; Dietz HC; Michaelis S Am J Med Genet A; 2013 Jul; 161A(7):1599-611. PubMed ID: 23666920 [TBL] [Abstract][Full Text] [Related]
12. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome. Finley J Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605 [TBL] [Abstract][Full Text] [Related]
13. Molecular insights into the premature aging disease progeria. Vidak S; Foisner R Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180 [TBL] [Abstract][Full Text] [Related]
14. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations. Gonzalo S; Kreienkamp R; Askjaer P Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497 [TBL] [Abstract][Full Text] [Related]
16. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. McClintock D; Gordon LB; Djabali K Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887 [TBL] [Abstract][Full Text] [Related]
17. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification. Chen X; Yao H; Andrés V; Bergo MO; Kashif M Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel RNA isoforms of LMNA. DeBoy E; Puttaraju M; Jailwala P; Kasoji M; Cam M; Misteli T Nucleus; 2017 Sep; 8(5):573-582. PubMed ID: 28857661 [TBL] [Abstract][Full Text] [Related]
20. Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn. Reunert J; Wentzell R; Walter M; Jakubiczka S; Zenker M; Brune T; Rust S; Marquardt T Eur J Hum Genet; 2012 Sep; 20(9):933-7. PubMed ID: 22419169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]